Penserra Capital Management LLC Geron Corp Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$1.22 - $1.72 $8,948 - $12,616	-7,335 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.2 - $1.5 $102 - $127	85 Added 1.17%	7,335 $10,000
Q2 2021 Aug 12, 2021	BUY	$1.25 - $1.83 $181 - $265	145 Added 2.04%	7,250 $10,000
Q1 2021 May 13, 2021	SELL	$1.52 - $2.1 $402 - $556	-265 Reduced 3.6%	7,105 $11,000
Q4 2020 Feb 12, 2021	BUY	$1.55 - $2.05 $7,312 - $9,671	4,718 Added 177.9%	7,370 $11,000
Q3 2020 Nov 13, 2020	BUY	$1.59 - $2.19 $4,216 - $5,807	2,652 New	2,652 $4,000

259

450M

1.91M

897K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.59B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.